MindMed Announces Financial Results for the Third Quarter 2021 and Business Highlights; Cash Balance of $145.9 USD ($185.4 CAD) to Execute on Diverse Clinical Pipeline

NEW YORK, Nov. 15, 2021 /CNW/ — MindMed (Nasdaq: MNMD, NEO: MMED, DE: MMQ), a leading biotech company developing psychedelic-inspired therapies, has announced its quarterly financial results for the quarter ended September 30, 2021. Third Quarter 2021 Financial Highlights (in USD) Cash Balance. Total assets as of September 30, 2021 were $178.6 million, including $145.9 million in cash…

Source